Ars Technica: Shkreli tells judge his drug discovery software is not for discovering drugs https://arstechnica.com/?p=1917489 #Tech #arstechnica #IT #Technology #Pharmaceuticalindustry #drugdevelopment #martinshkreli #pharmabro #Druglike #Science #Shkreli #FTC
#Tech #arstechnica #it #technology #pharmaceuticalindustry #drugdevelopment #martinshkreli #pharmabro #druglike #science #shkreli #FTC
Shkreli tells judge his drug discovery software is not for discovering drugs - Enlarge / Martin Shkreli arrives at Brooklyn Federal Court on the first... - https://arstechnica.com/?p=1917489 #pharmaceuticalindustry #drugdevelopment #martinshkreli #pharmabro #druglike #science #shkreli #ftc
#ftc #shkreli #science #druglike #pharmabro #martinshkreli #drugdevelopment #pharmaceuticalindustry
From 20 Jan: FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through a congressional he... https://arstechnica.com/science/2023/01/ftc-shkreli-may-have-violated-lifetime-pharma-ban-should-be-held-in-contempt/ #daraprim #drug-discovery #druglike #pharma #pharmaceutical-industry #policy #science #shkreli
#shkreli #science #policy #pharmaceutical #pharma #druglike #drug #daraprim
FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt - Enlarge / Martin Shkreli, former CEO of Turing, smirked his way through... - https://arstechnica.com/?p=1911591 #pharmaceuticalindustry #drugdiscovery #daraprim #druglike #science #shkreli #policy #pharma
#pharma #policy #shkreli #science #druglike #daraprim #drugdiscovery #pharmaceuticalindustry
Ars Technica: FTC: Shkreli may have violated lifetime pharma ban, should be held in contempt https://arstechnica.com/?p=1911591 #Tech #arstechnica #IT #Technology #Pharmaceuticalindustry #Drugdiscovery #daraprim #Druglike #Science #Shkreli #Policy #Pharma
#Tech #arstechnica #it #technology #pharmaceuticalindustry #drugdiscovery #daraprim #druglike #science #shkreli #policy #Pharma